Expression of wild-type and constitutively active PAK4 induced a significant increase in cellular proliferation in ovarian cancer cells [13], and it was reported to repress TGF-β-mediated growth inhibition in gastric cancer cells [14]. Here, PAK4 is linked to ovarian cancer.